COVID-19

Committed to being part of the COVID-19 solution

WE ARE JOINING YOU IN THE FIGHT

OUR GLOBAL TEAMS ARE IMPLEMENTING INNOVATIVE STRATEGIES TO ADDRESS THE CHALLENGES OF COVID-19.

Reach out to an expert
COVID-19

PPD helps Gilead advance studies of remdesivir as a COVID-19 treatment

PPD’s early, direct and ongoing experience managing COVID-19 trials includes helping Gilead advance the clinical development of remdesivir, its COVID-19 treatment.

Learn More

PPD collaborates with UK health research agencies on Roche COVID-19 study

With global attention on developing treatments and vaccines for COVID-19, speed is of the essence in responding to this worldwide challenge. PPD played an integral role in helping Roche achieve the recruitment target for its international tocilizumab study.

Learn More

Commitment to Our Employees, Patients and Customers

In these challenging times, our mission has never been more clearly in focus: to help our customers deliver life-changing therapies to patients in need.

HEAR FROM OUR CHAIRMAN AND CEO

SOLUTIONS CUSTOMIZED TO YOUR EVOLVING NEEDS

http://news
THE LATEST NEWS PPD Extends Digital Clinical Trial Capabilities to Support Biopharma Companies’ Research Continuity and Patient Safety during COVID-19 Pandemic Read more
http://Webinar
Webinar Are you ready to digitally-enable your trial? Key considerations for decentralizing and decreasing patient burden Register Now

TELEVISIT APPLICATION

PPD leverages key digital and operational capabilities to rescue and decentralize a study in a matter of days.

Continue Reading
Contact us

Do you have questions or want to discuss your evolving needs with PPD?